SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses

被引:34
|
作者
Elfiky, Abdo A. [1 ]
机构
[1] Cairo Univ, Biophys Dept, Fac Sci, Giza, Egypt
来源
FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷
关键词
GRP78; HSPA5; SARS-CoV-2; viral attachment; spike; host-cell recognition; COVID-19; cross-vaccination;
D O I
10.3389/fphar.2020.577467
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human coronavirus (HCoV), SARS-CoV-2, caused more than 34 M confirmed infections from which more than 1 M deaths are reported until now (the WHO situation report-154). The current pandemic causes severe socio-economic burden. Due to the importance of understanding of the mode of recognition and viral entry, spike protein shed drug designers as the first look protein target with the first released solved structure on 26 February 2020 (PDB ID: 6VSB). It is proposed that the recognition site for GRP78 is found in SARS-CoV-2 and the immersed human coronaviruses but experimental validation is still required.
引用
收藏
页数:3
相关论文
共 35 条
  • [11] Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission
    Cotten, Matthew
    Phan, My V. T.
    ISCIENCE, 2023, 26 (03)
  • [12] Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection (vol 13, 132, 2020)
    Palmeira, Andreia
    Sousa, Emilia
    Koseler, Aylin
    Sabirli, Ramazan
    Goren, Tarik
    Turkcuer, Ibrahim
    Kurt, Ozgur
    Pinto, Madalena M.
    Vasconcelos, M. Helena
    PHARMACEUTICALS, 2024, 17 (04)
  • [13] Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein
    Ryota Otsubo
    Takeharu Minamitani
    Kouji Kobiyama
    Junso Fujita
    Toshihiro Ito
    Shiori Ueno
    Itsuki Anzai
    Hiroki Tanino
    Hiroshi Aoyama
    Yoshiharu Matsuura
    Keiichi Namba
    Ken-Ichi Imadome
    Ken J. Ishii
    Kouhei Tsumoto
    Wataru Kamitani
    Teruhito Yasui
    Scientific Reports, 12
  • [14] Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein
    Otsubo, Ryota
    Minamitani, Takeharu
    Kobiyama, Kouji
    Fujita, Junso
    Ito, Toshihiro
    Ueno, Shiori
    Anzai, Itsuki
    Tanino, Hiroki
    Aoyama, Hiroshi
    Matsuura, Yoshiharu
    Namba, Keiichi
    Imadome, Ken-Ichi
    Ishii, Ken J.
    Tsumoto, Kouhei
    Kamitani, Wataru
    Yasui, Teruhito
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [15] Interaction Between SARS-CoV-2 Spike Protein S1 Subunit and Oyster Heat Shock Protein 70
    Li, Jingwen
    Lyu, Chenang
    An, Ran
    Wang, Dapeng
    FOOD AND ENVIRONMENTAL VIROLOGY, 2024, 16 (03) : 380 - 390
  • [16] The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein
    Shin, Woo-Jin
    Ha, Dat P.
    Machida, Keigo
    Lee, Amy S.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [17] The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein
    Woo-Jin Shin
    Dat P. Ha
    Keigo Machida
    Amy S. Lee
    Nature Communications, 13
  • [18] Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein
    Hussain, Mushtaq
    Jabeen, Nusrat
    Raza, Fozia
    Shabbir, Sanya
    Baig, Ayesha A.
    Amanullah, Anusha
    Aziz, Basma
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1580 - 1586
  • [19] Vulnerability of The Male Reproductive System to SARS-CoV-2 Invasion: Potential Role for The Endoplasmic Reticulum Chaperone Grp78/HSPA5/BiP
    Sadeghi, Niloofar
    Tavalaee, Marziyeh
    Shahverdi, Abdolhossein
    Sengupta, Pallav
    Leisegang, Kristian
    Saleh, Ramadan
    Agarwal, Ashok
    Nasr-Esfahani, Mohammad Hossein
    CELL JOURNAL, 2022, 24 (08) : 427 - 433
  • [20] A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses
    Cai, Yanxing
    Xu, Wei
    Tang, Jiayi
    Cao, Najing
    Lan, Qiaoshuai
    Lu, Lu
    Jiang, Shibo
    CELL AND BIOSCIENCE, 2021, 11 (01):